Advertisement

Topics

Pfizer Oncology Company Profile

23:50 EST 16th December 2018 | BioPortfolio

Pfizer Oncology is committed to the discovery, investigation and development of innovative treatment options to improve the outlook for cancer patients worldwide. Our strong pipeline, one of the most robust in the industry, is studied with precise focus on identifying and translating the best scientific breakthroughs into clinical application for patients across a wide range of cancers, including breast, lung, prostate, sarcoma, melanoma, and various hematologic cancers. Pfizer Oncology has biologics and small molecules in clinical development and more than 200 clinical trials underway. By working collaboratively with academic institutions, individual researchers, cooperative research groups, governments, and licensing partners, Pfizer Oncology strives to cure or control cancer with breakthrough medicines, to deliver the right drug for each patient at the right time. For more information please visit www.Pfizer.com.


News Articles [1716 Associated News Articles listed on BioPortfolio]

Pfizer unveils its first oncology biosimilar in Europe

The European Commission (EC) has approved trazimera (trastuzumab), Pfizer’s biosimilar to Roche’s Herceptin, making it Pfizer’s first oncology biosimilar to...Read More... The post Pfizer unveil...

Pfizer Receives European Approval for Oncology Biosimilar, TRAZIMERA (trastuzumab)

The European Commission decision marks the approval of Pfizer's first therapeutic oncology biosimilar Pfizer Inc. (NYSE:PFE) today announced the European Commission (EC) has approved TRAZIMERA,1 a...

Pfizer nabs fourth oncology approval in two months

The FDA has approved Pfizer’s new drug, Daurismo, for patients with acute myeloid leukemia.

Nektar Therapeutics And Pfizer Enter Into New Clinical Oncology Collaboration

NEW YORK CITY (dpa-AFX) - Nektar Therapeutics (NKTR) said that it has entered into an oncology clinical collaboration with Pfizer Inc. (PFE) to evaluate several combination regimens in multiple ca...

Pfizer wins Herceptin biosimilar approval in Europe

European Commission (EC) has approved Pfizer’s Trazimera, for breast and gastric cancer treatment, marking it as pharma’s first oncology biosimilar to receive approval in the EU. It is the fourt...

AstraZeneca Tagrisso, Pfizer Xalkori Stand Out Among US FDA’s Single-Arm Oncology Approvals, JAMA Suggests

Only two US approvals based on single-arm trials met the European Society for Medical Oncology’s threshold for substantial clinical benefit...   

EC approves Pfizer's Herceptin biosimilar

Copycat of blockbuster breast cancer drug is Pfizer's first oncology biosimilar

License Agreement: Clovis Onclology $CLVS (Pfizer, $PFE)

June 2011, Clovis Oncology ($CLVS @ClovisOncology) entered into a license agreement with Pfizer ($PFE @Pfizer) to obtain exclusive global rights to develop and commercialize rucaparib. The rights ar...

Drugs and Medications [108 Associated Drugs and Medications listed on BioPortfolio]

Preparation h [Pfizer Consumer Healthcare]

Preparation H Suppositories(cocoa butter and phenylephrine HCl)

Chapstick overnight [Pfizer Consumer Healthcare]

ChapStick Overnight Lip Treatment (dimethicone)

Preparation h [Pfizer Consumer Healthcare]

Preparation H Hemorrhoidal Ointment (mineral oil, petrolatum and phenylephrine HCl)

Anbesol cold sore therapy [Pfizer Consumer Healthcare]

Anbesol Cold Sore Therapy(allantoin, benzocaine, camphor, and white petrolatum)

Chapstick lipshield 365 [Pfizer Consumer Healthcare]

Chapstick LipShield 365(avobenzone, dimethicone, homosalate, octinoxate, octisalate, and oxybenzone)

PubMed Articles [1288 Associated PubMed Articles listed on BioPortfolio]

Conserved cysteines in Mason-Pfizer monkey virus capsid protein are essential for infectious mature particle formation.

Retrovirus assembly is driven mostly by Gag polyprotein oligomerization, which is mediated by inter and intra protein-protein interactions among its capsid (CA) domains. Mason-Pfizer monkey virus (M-P...

Share of Oncology Versus Nononcology Spending in Episodes Defined by the Centers for Medicare & Medicaid Services Oncology Care Model.

Performance-based payments to oncology providers participating in the Centers for Medicare & Medicaid Services (CMS) Oncology Care Model (OCM) are based, in part, on overall spending in 6-month episod...

Burnout and Resiliency in Canadian Oncology Residents: a Nationwide Resident and Program Director Survey.

To measure burnout rates and resiliency scores in Canadian Oncology residents and to advance the knowledge regarding resiliency and wellness training in Canadian Oncology residency programs.

Development of a Virtual Radiation Oncology Clinic for training and simulation of errors in the radiation oncology workflow.

Integrative Oncology Scholars Program: A Model for Integrative Oncology Education.

Oncology providers are often confronted by patients who use complementary or alternative therapies, but have limited knowledge or confidence on how to advise patients on appropriate use. Despite this,...

Clinical Trials [649 Associated Clinical Trials listed on BioPortfolio]

Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04)

This extension study will evaluate the safety (including immunogenicity) of treatment with rituximab-Pfizer, as well as the safety and immunogenicity after transitioning from rituximab-US ...

A Study Comparing Blood Levels After Single-Dose Administration Of Artesunate Sachets (Pfizer) Versus Single-Dose Administration Of Arsuamoon® Tablets (Guilin-China) In Healthy Subjects

The primary objective of the study is to determine bioequivalence of 50 mg (2x25 mg) Artesunate Sachet (Pfizer) versus 50 mg (1x50 mg) tablet, Arsuamoon® (Guilin China) which is the World...

A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07))

This is a Phase 1, double blind (sponsor open), randomized (1:1:1), parallel group, 3 arm, single dose comparative PK study of adalimumab Pfizer and adalimumab sourced from the US and EU a...

A Bioequivalence Study Comparing Amodiaquine Tablet (Pfizer) To Amodiaquine Tablets (Arsuamoon-Guilin China) In Healthy Subjects

The study will determine if amodiaquine tablet (Pfizer), an antimalaria agent, is pharmaceutically equivalent to a comparator product (Arsuamoon-Guilin China).

Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System

The purpose of this study is to learn what cancer patients think about IBM Watson Oncology. IBM Watson Oncology is a computer program designed to help inform oncologists about the best che...

Companies [859 Associated Companies listed on BioPortfolio]

Pfizer Oncology

Pfizer Oncology is committed to the discovery, investigation and development of innovative treatment options to improve the outlook for cancer patients worldwide. Our strong pipeline, one of the most...

The Pfizer Foundation

The Pfizer Foundation is a charitable organization established by Pfizer Inc. The Foundation is a separate and independent tax-exempt organization. The Foundation’s mission i...

Renata Limited

Historical High-Lights: Founded in 1972 as a subsidiary of Pfizer Inc. Ownership transferred from Pfizer Inc. to local institutions and the general public in 1993. Company name subsequently changed fr...

Pfizer Ophthalmics

Pfizer Ophthalmics, a division of Pfizer Inc, is committed to preserving sight and eliminating preventable blindness. Pfizer Ophthalmics discovers, develops and provides leading treatments in ophthalm...

Bristol-Myers Squibb Company & Pfizer Inc.

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize ELIQUIS, an investigational oral anticoagulant discovered by Bristol-M...

More Information about "Pfizer Oncology" on BioPortfolio

We have published hundreds of Pfizer Oncology news stories on BioPortfolio along with dozens of Pfizer Oncology Clinical Trials and PubMed Articles about Pfizer Oncology for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pfizer Oncology Companies in our database. You can also find out about relevant Pfizer Oncology Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record